Please note our upcoming holiday hours. We will be CLOSED from December 25th to 28th and on January 1st. We’ll be OPEN for a half-day on December 24th and 31st, with regular hours resuming on January 2nd. “Happy Holidays”
15% off first order with code: 1storder
Competitive Prices
Gonadorelin peptide is a synthetic form of gonadotropin-releasing hormone (GnRH) designed to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This peptide plays a critical role in research focused on reproductive system health, hormone regulation, and fertility. It serves as a valuable tool for studying conditions such as hypogonadism and other hormonal imbalances.
Gonadorelin is widely utilized in laboratory settings to explore hormonal pathways, offering insights into the complex mechanisms of the endocrine system. Its precise action and research applications make it indispensable in advancing our understanding of reproductive biology and hormone therapy [1].
Molecular Formula: C55H75N17O13
Amino Acids Sequence: H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
Molecular Weight: 1182.3 g/mol
View the Gonadorelin HPLC Certificate here.
Source: PubChem
Buy Gonadorelin Peptide Vial here – Available in 2 mg dosage vials for laboratory purposes from PharmaLabGlobal.
Gonadorelin is a synthetic replicon of the Gonadotropin Releasing Hormone (GnRH), a key intermediary in the hypothalamic pituitary gonad axis. It works on receptor sites located on the anterior pituitary gland, just like natural GnRH. This interaction prompts release of both matter luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). These two hormones are essentially what determine a body’s reproductive health or its general endocrine controls [2].
LH stimulates the production of testosterone in the Leydig cells of the testes in males, which is essential for sperm production and maintaining secondary sexual characteristics. In females, LH promotes ovulation and the formation of the corpus luteum, which produces progesterone during the menstrual cycle [3].
Meanwhile, FSH supports gamete production by stimulating spermatogenesis in males and follicular development in females. Gonadorelin’s precise mechanism enables researchers to explore hormonal pathways, evaluate fertility treatments, and study conditions like hypogonadism or hormonal imbalances effectively.
Peptide Nasal Sprays provide a convenient and efficient delivery to peptide administration. Buy Gonadorelin Nasal Spray for research purposes – available in 15 ml or 30ml bottles.
Gonadorelin is a widely used peptide therapy in fertility medical treatments. In clinical settings Gonadorelin has demonstrated the following uses:
Stimulates the release of LH and FSH from the pituitary gland
Further research has shown that Gonadorelin stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by mimicking the natural gonadotropin-releasing hormone (GnRH). It binds to GnRH receptors located on the anterior pituitary gland, triggering a signaling cascade that results in the secretion of LH and FSH into the bloodstream.
Effects of LH and FSH:
In males the Lutieinizing hormone stimulates the Leydig cells in the testes to produce testosterone, which is essential for sperm production, maintaining secondary sexual characteristics, and overall reproductive health.
The folicle stimulating hormone supports spermatogenesis by acting on the Sertoli cells in the testes, aiding in the maturation of sperm.
In females, the LH triggers ovulation and supports the formation of the corpus luteum, which produces progesterone necessary for maintaining the uterine lining during the menstrual cycle. Whilst the FSH promotes the growth and maturation of ovarian follicles, preparing them for ovulation.
This mechanism is critical for regulating reproductive health and is often leveraged in fertility treatments and research to address hormonal imbalances or reproductive disorders [4] [5].
Promotes Fertility
The Gonadorelin peptide is often utilized in fertility treatments due to its ability to mimic the natural gonadotropin-releasing hormone (GnRH), a key regulator of the hypothalamic pituitary gonadal axis. By binding to GnRH receptors on the anterior pituitary gland, Gonadorelin stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), essential hormones for reproductive health.
In women, Gonadorelin can help regulate ovulation. By promoting LH secretion, it triggers ovulation, whilst the FSH supports the development and maturation of ovarian follicles. This makes it particularly beneficial in controlled ovarian stimulation during in vitro fertilization (IVF) or other assisted reproductive therapies. It is also effective for patients with hypogonadotropic hypogonadism, a condition characterized by low GnRH, which leads to insufficient LH and FSH levels, impairing ovulation.
For men, Gonadorelin also plays a role in treating male infertility. It promotes LH release, which stimulates testosterone production in the Leydig cells of the testes, essential hormones for sperm production. FSH further supports spermatogenesis by enhancing the maturation of sperm within the Sertoli cells.
This precise hormonal regulation allows Gonadorelin to correct underlying hormonal deficiencies, helping patients achieve enhanced fertility [6].
Treats Hypogonadism
Gonadorelin is an effective treatment option for hypogonadism, a condition characterized by insufficient or absent production of sex hormones due to hypothalamic or pituitary dysfunction. By mimicking the natural gonadotropin-releasing hormone (GnRH), Gonadorelin directly targets the underlying hormonal imbalances typical of this condition.
When administered, Gonadorelin binds to GnRH receptors in the anterior pituitary gland, activating a signaling pathway that promotes the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These gonadotropins are essential in regulating reproductive function and correcting sex hormone deficiencies [4].
Potential Cancer Treatment
Gonadorelin has shown promise in cancer treatment through various studies. Research suggests that GnRH agonists, like Gonadorelin, can reduce the growth and recurrence of breast cancer, particularly in patients with triple-negative breast cancer (TNBC). Additionally, in metastatic cancers such as breast, ovarian, and endometrial cancers, GnRH has been found to decrease cell invasion and metastasis. Another significant application of GnRH agonists is their use during chemotherapy for ovarian suppression, which helps preserve ovarian function and may improve treatment outcomes [7].
Buy Gonadorelin Pre-Mixed Peptide Pen. Pen kits are supplied with Gonadorelin cartridges already reconstituted with Bacteriostatic Water. Buy Gonadorelin Spain for research use from PharmaLabGlobal.
Buy Gonadorelin today!
Can Gonadorelin treat delayed puberty?
Gonadorelin is often used to mimic the natural release of GnRH from the hypothalamus. It helps treat delayed puberty or fertility issues caused by hypogonadotropic hypogonadism, a condition where low GnRH, FSH, or LH leads to a lack of sex hormones. It is also used to trigger ovulation in women with hypothalamic amenorrhea, a condition where a female experiences an absence of menstruation due to insufficient GnRH.
Can Gonadorelin have any side effects?
Yes, Gonadorelin can have side effects. Common ones include headache, nausea, mild abdominal discomfort, flushing, and light headedness. Injection site reactions, such as redness, irritation, or bruising, may also occur.
In rare cases, more severe symptoms like severe stomach pain, bloating, or significant weight gain may arise. If you experience any concerning symptoms, it’s important to consult a healthcare professional.
[1] Sepideh Khazeni, Pegah Varamini, Gonadotropin Releasing Hormone, Reference Module in Biomedical Sciences, Elsevier, 2018
[2] Craig McArdle, Gonadotropin Releasing Hormone (GnRH) Receptor, Editor(s): S.J. Enna, David B. Bylund, xPharm: The Comprehensive Pharmacology Reference, Elsevier, 2007, Pages 1-12.
[3] Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles. Gynecol Endocrinol. 2014 Mar;30(3):174-81.
[4] Rajkanna J, Tariq S, Oyibo SO. Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism. Endocrinol Diabetes Metab Case Rep. 2016;2016:150124.
[5] Martínez M, Mapletoft RJ, Kastelic JP, Carruthers T. The effects of 3 gonadorelin products on luteinizing hormone release, ovulation, and follicular wave emergence in cattle. Can Vet J. 2003 Feb;44(2):125-31.
[6] S. Wray, Gonadotropin-Releasing Hormone: GnRH-1 System, Editor(s): Larry R. Squire, Encyclopedia of Neuroscience, Academic Press, 2009, Pages 967-973.
[7] Huerta-Reyes M, Maya-Núñez G, Pérez-Solis MA, López-Muñoz E, Guillén N, Olivo-Marin JC, Aguilar-Rojas A. Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs. Front Oncol. 2019 Oct 1;9:943.
Gonadorelin Peptide vs HCG in Research
This article compares Gonadorelin peptide and HCG, focusing on their roles in hormonal regulation and reproductive health research. Gonadorelin, a synthetic GnRH, stimulates the pituitary gland to release LH and FSH, supporting natural hormonal cycles and long-term balance. In contrast, HCG mimics LH directly, bypassing the pituitary gland, making it effective for short-term testosterone or ovulation stimulation but less ideal for maintaining natural hormonal rhythms. The blog highlights Gonadorelin’s advantages in fertility and testosterone studies, emphasizing its ability to preserve natural feedback loops, while noting HCG’s utility in specific reproductive scenarios.
Can Peptides Like Gonadorelin Change Testosterone Replacement Therapy?
This blog explores the potential role of Gonadorelin in testosterone replacement therapy (TRT) and peptide research. It highlights how Gonadorelin, a synthetic version of gonadotropin-releasing hormone (GnRH), stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to promote natural testosterone production. Unlike traditional TRT, which involves external testosterone administration and can suppress natural production, Gonadorelin may offer a more natural approach by maintaining hormonal balance and potentially preserving fertility.
FOXO4-DRI the Future of Age-Related Testosterone Insufficiency
We discuss testosterone insufficiency, its causes, and potential peptide-based treatments. It highlights how aging, stress, and medical conditions can lead to low testosterone levels, affecting energy, mood, and physical health. Peptides like FOXO4-DRI, HCG, Triptorelin, and Gonadorelin are explored for their ability to stimulate natural testosterone production, offering a potential alternative to traditional testosterone replacement therapy (TRT). These peptides aim to restore hormonal balance by targeting natural pathways, though they remain in the research phase and are not yet approved for general use. The blog emphasizes the promise of peptide therapies in managing testosterone insufficiency.
Peptides are manufactured to a purity standard of 99% (complex peptides are 98% pure or higher)
At Pharma Lab Global we supply premium peptides to the research industry worldwide.
Our mission and priority are to ensure that clients receive a superior customer experience.
At Pharma Lab Global we aim to supply the highest purity research peptides at affordable prices.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by Pharma Lab Global are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.
